SS Innovations International (SSII) Change in Account Payables (2022 - 2026)
SS Innovations International recorded quarterly Change in Account Payables of -$704764.0 in Q1 2026, down 232.17% quarter-over-quarter from $533226.0 in Q4 2025, and down 153.03% year-over-year from $1.3 million in Q1 2025.
SS Innovations International's Change in Account Payables history runs 5 years deep, the most recent figure standing at -$704764.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 153.03% year-over-year to -$704764.0; the TTM figure through Mar 2026 stood at $844018.0 (down 53.47% YoY), while the FY2025 annual figure was $2.9 million, up 103.98% from the prior year.
- Change in Account Payables came in at -$704764.0 for Q1 2026 at SS Innovations International, down from $533226.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.5 million in Q2 2025 to a low of -$1.4 million in Q3 2025.
- A 5-year average of $297829.7 and a median of $183467.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 11752.61% in 2024 and tumbled 313.89% in 2025, its largest moves.
- SS Innovations International's Change in Account Payables stood at -$35973.0 in 2022, then surged by 604.54% to $181498.0 in 2023, then surged by 183.07% to $513770.0 in 2024, then rose by 3.79% to $533226.0 in 2025, then sank by 232.17% to -$704764.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$704764.0, $533226.0, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | -704,764.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -704,764.00 |
| Mar 31, 2026 | -704,764.00 |
| Dec 31, 2025 | 533,226.00 |
| Dec 31, 2025 | 533,226.00 |
| Sep 30, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 513,770.00 |
| Dec 31, 2024 | 513,770.00 |
| Sep 30, 2024 | 672,239.00 |
| Sep 30, 2024 | 672,239.00 |
| Jun 30, 2024 | -701,262.00 |
| Jun 30, 2024 | -701,262.00 |
| Mar 31, 2024 | 926,083.00 |
| Mar 31, 2024 | 926,083.00 |
| Dec 31, 2023 | 181,498.00 |
| Dec 31, 2023 | 181,498.00 |
| Sep 30, 2023 | -5,769.00 |
| Sep 30, 2023 | -5,769.00 |
| Jun 30, 2023 | 410,009.00 |
| Jun 30, 2023 | 410,009.00 |
| Mar 31, 2023 | 150,337.00 |
| Mar 31, 2023 | 150,337.00 |
| Dec 31, 2022 | -35,973.00 |
| Dec 31, 2022 | -35,973.00 |
| Sep 30, 2022 | 183,467.00 |
| Sep 30, 2022 | 183,467.00 |